
Annual report 2025
added 03-14-2026
Alcon Net Debt 2011-2026 | ALC
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt Alcon
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 2.46 B | 2.74 B | 1.6 B | -23 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.74 B | -23 M | 1.69 B |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Medical instruments industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
-104 M | $ 29.85 | 1.05 % | $ 1.43 B | ||
|
AngioDynamics
ANGO
|
-48.3 M | $ 10.6 | -1.03 % | $ 433 M | ||
|
Luminex Corporation
LMNX
|
-106 M | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
-517 K | - | -9.52 % | $ 20.6 M | ||
|
Atrion Corporation
ATRI
|
-45 M | - | - | $ 810 M | ||
|
Harvard Bioscience
HBIO
|
27.8 M | $ 0.47 | -4.15 % | $ 19.9 M | ||
|
Antares Pharma, Inc.
ATRS
|
-12.2 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
781 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
66.8 M | - | - | $ 282 M | ||
|
ICU Medical
ICUI
|
972 M | $ 125.85 | -2.28 % | $ 3.1 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
1.58 B | - | -0.05 % | $ 10.3 B | ||
|
InfuSystem Holdings
INFU
|
33.3 M | $ 9.31 | -0.85 % | $ 192 M | ||
|
iRhythm Technologies
IRTC
|
-154 M | $ 113.0 | -1.46 % | $ 3.62 B | ||
|
Intuitive Surgical
ISRG
|
-3.2 B | $ 472.16 | -1.48 % | $ 169 B | ||
|
The Cooper Companies
COO
|
2.38 B | $ 69.92 | -2.24 % | $ 13.9 B | ||
|
Varian Medical Systems, Inc.
VAR
|
-411 M | - | -0.02 % | $ 16.3 B | ||
|
Glaukos Corporation
GKOS
|
-21.6 M | $ 97.02 | -0.79 % | $ 4.7 B | ||
|
Becton, Dickinson and Company
BDX
|
17.1 B | $ 159.36 | -0.17 % | $ 45.8 B | ||
|
Haemonetics Corporation
HAE
|
623 M | $ 59.92 | 0.72 % | $ 3.02 B | ||
|
electroCore
ECOR
|
-9.7 M | $ 6.14 | -3.0 % | $ 33.9 K | ||
|
Masimo Corporation
MASI
|
572 M | $ 175.49 | -0.01 % | $ 9.35 B | ||
|
Isoray
ISR
|
-58.9 M | - | 0.03 % | $ 108 M | ||
|
Predictive Oncology
POAI
|
1.4 M | - | - | $ 31.1 M | ||
|
Ekso Bionics Holdings
EKSO
|
-581 K | $ 11.56 | -2.12 % | $ 28 M | ||
|
Repro Med Systems
KRMD
|
-8.38 M | $ 4.28 | -0.7 % | $ 198 M | ||
|
Baxter International
BAX
|
7.55 B | $ 17.4 | -3.36 % | $ 8.93 B | ||
|
BioLife Solutions
BLFS
|
-88.9 M | $ 18.36 | 1.16 % | $ 846 M | ||
|
Nephros
NEPH
|
-2.48 M | $ 3.5 | -7.89 % | $ 36.4 M | ||
|
ResMed
RMD
|
513 M | $ 230.84 | -0.68 % | $ 33.7 B | ||
|
Retractable Technologies
RVP
|
-3 M | $ 0.71 | 2.62 % | $ 21.3 M | ||
|
NeuroMetrix
NURO
|
-1.49 M | - | 5.05 % | $ 9.02 M | ||
|
Merit Medical Systems
MMSI
|
299 M | $ 69.95 | 2.61 % | $ 4.14 B | ||
|
Envista Holdings Corporation
NVST
|
276 M | $ 24.61 | -3.26 % | $ 4.13 B | ||
|
STAAR Surgical Company
STAA
|
-115 M | $ 18.84 | 2.45 % | $ 934 M | ||
|
Stereotaxis
STXS
|
-7.98 M | $ 1.89 | 0.27 % | $ 172 M | ||
|
Teleflex Incorporated
TFX
|
2.26 B | $ 107.32 | -0.87 % | $ 4.79 B | ||
|
OraSure Technologies
OSUR
|
-197 M | $ 2.97 | -3.88 % | $ 218 M | ||
|
LeMaitre Vascular
LMAT
|
143 M | $ 108.06 | 1.43 % | $ 2.45 B | ||
|
Utah Medical Products
UTMD
|
-60.6 M | $ 63.28 | 1.02 % | $ 230 M | ||
|
Pro-Dex
PDEX
|
15 M | $ 48.46 | 3.5 % | $ 159 M | ||
|
Microbot Medical
MBOT
|
-2.24 M | $ 2.69 | -1.47 % | $ 27.4 M | ||
|
West Pharmaceutical Services
WST
|
-566 M | $ 235.46 | 1.89 % | $ 17 B | ||
|
Repligen Corporation
RGEN
|
-236 M | $ 114.2 | 0.39 % | $ 6.36 M | ||
|
DENTSPLY SIRONA
XRAY
|
1.74 B | $ 11.54 | -2.2 % | $ 2.3 B | ||
|
Pulse Biosciences
PLSE
|
-73.2 M | $ 21.57 | 1.27 % | $ 1.45 B | ||
|
STERIS plc
STE
|
1.78 B | $ 214.57 | 1.05 % | $ 21.2 B | ||
|
Milestone Scientific
MLSS
|
-3.09 M | $ 0.28 | -3.75 % | $ 22.3 M |